通过胰岛素抵抗指数测定的曲格列酮疗效。 - Suppr

Suppr

超能文献

Efficacy of troglitazone measured by insulin resistance index.

作者信息

Nagasaka S, Iwamoto Y, Ishikawa S, Kuzuya T, Saito T

出版信息

Lancet. 1997 Jul 19;350(9072):184. doi: 10.1016/s0140-6736(05)62350-1.

DOI:10.1016/s0140-6736(05)62350-1

PMID:9250189

Abstract

摘要

相似文献

Efficacy of troglitazone measured by insulin resistance index.

Lancet. 1997 Jul 19;350(9072):184. doi: 10.1016/s0140-6736(05)62350-1.

Learning to use troglitazone.

Diabetes Care. 1998 Sep;21(9):1389-90. doi: 10.2337/diacare.21.9.1389.

New diabetes drug targets insulin resistance.

Am J Health Syst Pharm. 1997 Mar 15;54(6):623, 625. doi: 10.1093/ajhp/54.6.623.

Troglitazone: a new antihyperglycemic agent.

Cleve Clin J Med. 1997 May;64(5):238-40. doi: 10.3949/ccjm.64.5.238.

Troglitazone and small low-density lipoprotein in type 2 diabetes.

Ann Intern Med. 1998 Jul 15;129(2):162-3. doi: 10.7326/0003-4819-129-2-199807150-00030.

New directions in treating insulin resistance.

Hosp Pract (1995). 1995 Sep 15;30(9):9-10. doi: 10.1080/21548331.1995.11443246.

Effect of troglitazone on lipoprotein(a) levels in obese subjects.

Diabetes Care. 1999 Oct;22(10):1752-3. doi: 10.2337/diacare.22.10.1752.

[Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].

Duodecim. 1997;113(19):1847-8.

[A 75-year-old type 2 diabetes mellitus case responding strikingly troglitazone: possible mechanism of insulin resistance induced by insulin antibody].

Nihon Ronen Igakkai Zasshi. 2000 Apr;37(4):344-8. doi: 10.3143/geriatrics.37.344.

New therapeutic approaches to reversing insulin resistance.

Curr Opin Nephrol Hypertens. 1998 Sep;7(5):551-5. doi: 10.1097/00041552-199809000-00011.

引用本文的文献

Misuse of correlation and regression in three medical journals.

J R Soc Med. 1999 Mar;92(3):123-8. doi: 10.1177/014107689909200306.

Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians.

Heart. 1999 May;81(5):501-4. doi: 10.1136/hrt.81.5.501.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Efficacy of troglitazone measured by insulin resistance index.

Lancet. 1997 Jul 19;350(9072):184. doi: 10.1016/s0140-6736(05)62350-1.

Learning to use troglitazone.

Diabetes Care. 1998 Sep;21(9):1389-90. doi: 10.2337/diacare.21.9.1389.

New diabetes drug targets insulin resistance.

Am J Health Syst Pharm. 1997 Mar 15;54(6):623, 625. doi: 10.1093/ajhp/54.6.623.

Troglitazone: a new antihyperglycemic agent.

Cleve Clin J Med. 1997 May;64(5):238-40. doi: 10.3949/ccjm.64.5.238.

Troglitazone and small low-density lipoprotein in type 2 diabetes.

Ann Intern Med. 1998 Jul 15;129(2):162-3. doi: 10.7326/0003-4819-129-2-199807150-00030.

New directions in treating insulin resistance.

Hosp Pract (1995). 1995 Sep 15;30(9):9-10. doi: 10.1080/21548331.1995.11443246.

Effect of troglitazone on lipoprotein(a) levels in obese subjects.

Diabetes Care. 1999 Oct;22(10):1752-3. doi: 10.2337/diacare.22.10.1752.

[Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].

Duodecim. 1997;113(19):1847-8.

[A 75-year-old type 2 diabetes mellitus case responding strikingly troglitazone: possible mechanism of insulin resistance induced by insulin antibody].

Nihon Ronen Igakkai Zasshi. 2000 Apr;37(4):344-8. doi: 10.3143/geriatrics.37.344.

New therapeutic approaches to reversing insulin resistance.

Curr Opin Nephrol Hypertens. 1998 Sep;7(5):551-5. doi: 10.1097/00041552-199809000-00011.

引用本文的文献

Misuse of correlation and regression in three medical journals.

J R Soc Med. 1999 Mar;92(3):123-8. doi: 10.1177/014107689909200306.

Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians.

Heart. 1999 May;81(5):501-4. doi: 10.1136/hrt.81.5.501.